Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca’s Oral Anticoagulant AZD0837 Phase III Program Pushed Back To 2009

Related Content

Targacept’s AstraZeneca Deal Down, Not Out

Sep 16 2008

Learning From Exanta: AstraZeneca Ready For Phase III With ‘0837

Aug 04 2008

Stars Align For AstraZeneca In JUPITER Trial

Mar 31 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window